disease | Pediatric Amebiasis |
The main pathogen of amoebiasis is Entamoeba histolytica. This protozoan most commonly invades the colon in humans, causing amoebic dysentery. When it invades organs such as the liver, lungs, or brain, it can also cause corresponding organ lesions, with liver involvement being the most common.
bubble_chart Clinical Manifestations
bubble_chart Auxiliary Examination
Epidemiological history includes consumption of unclean food in endemic areas or close contact with patients affected by the disease.
bubble_chart Treatment Measures
Treatment
(1) General Management For dehydration and acidosis, fluid therapy should be administered for correction. During the acute phase, a residue-free diet is recommended, while in the chronic phase, attention should be paid to nutritional supplementation and anemia correction. (2) Pathogenic Treatment Anti-amoebic therapy should be timely and thorough. After completing the course, stool tests should be conducted, and if necessary, 1–2 additional courses should be repeated to prevent relapse. The following medications are available for selection. 1. **Metronidazole** Effective against all types of amoebic protozoa. Dose: 50 mg/(kg·d), divided into 3 doses, with a maximum daily dose not exceeding 1 g. The treatment course lasts 7 days. Side effects such as nausea, abdominal pain, or dizziness generally require no special intervention; however, if ataxia or similar symptoms occur, the medication should be discontinued immediately. 2. **Tinidazole** Effective against all types and locations of amoebiasis. Dose: 50 mg/(kg·d), administered in a single dose. The treatment course lasts 5 days. 3. **Chiniofon (Yatren)** Used for acute and chronic amoebic dysentery but ineffective for extraintestinal amoebiasis. Dose: 40–45 mg/(kg·d), divided into 3 doses, with a treatment course of 8–10 days. Alternatively, a 1% solution can be prepared with saline for retention enemas (100–200 ml per session). Oral administration and enemas can be alternated every other day, with a total course of 8–10 days. 4. **Iodochlorhydroxyquin (Vioform)** Similar in action to chiniofon. Dose: 15–30 mg/(kg·d), divided into 3 oral doses, with a treatment course of 10 days. 5. **Phanguone (Entobex)** Used for acute and chronic amoebic dysentery. For older children: 100 mg per dose, 3 times daily, with a 10-day course. Dosage should be reduced for younger children. 6. **Emetine HCl** Kills amoebic trophozoites. Dose: 0.5–1 mg/(kg·d), administered via deep subcutaneous or intramuscular injection, divided into 2 doses daily. The treatment course lasts 4–5 days. Before injection, patients should rest in bed, and blood pressure and pulse should be monitored. If abdominal pain, weakness, arrhythmia, or hypotension occurs, the medication should be discontinued immediately. Contraindicated in young children. If a repeat course is needed, an interval of at least 6 weeks is required. Due to high toxicity, it is now rarely used. 7. **Carbarsone** Effective against both amoebic trophozoites and cysts, used for acute/chronic amoebic dysentery and relapse prevention. Primarily for older children. Dose: 8 mg/(kg·d), divided into 2–3 oral doses, with a 10-day course. 8. **Paromomycin** Used for acute and chronic amoebic dysentery. Dose: 20–30 mg/(kg·d), divided into 4 oral doses, with a 7–10 day course. This drug has limited efficacy when used alone and is best combined with other anti-amoebic agents. **Prevention** (1) Maintain personal and dietary hygiene, improve environmental sanitation, eliminate flies and cockroaches, and strengthen water source management. (2) Isolate patients until stool tests are negative three times. Chronic cases working in the food industry should receive thorough treatment and be temporarily reassigned during therapy.
The main differentiation should be made from bacterial dysentery. The latter usually has an acute onset, with fever or even high fever, obvious toxic symptoms, and stools primarily consisting of mucus, pus, and blood.